China National Accord Medicines Corp. Hits Day Low Amid Price Pressure at CNY 24.24

China National Accord Medicines Corp. experienced a notable decline today, with the stock dropping by 5.59% as it reached an intraday low of CNY 24.24. This performance contrasts with the China Shanghai Composite, which fell by 3.63% on the same day. Over the past week, the stock has decreased by 5.12%, while its one-month performance shows a decline of 5.08%. In terms of longer-term performance, China National Accord Medicines has faced challenges, with a significant drop of 46.23% over the past three years and a 63.01% decrease over the last decade. The company has reported negative results for the last four consecutive quarters, highlighting ongoing difficulties in its financial metrics. Despite a high dividend yield of 1.44%, the stock's return on equity stands at a modest 0.99%, and its price-to-book ratio is 0.67. The company’s market capitalization is CNY 12,324 million, categorizing it as a large-cap entity within the pharmaceuticals and biotechnology industry.